Summary

for people ages 13 years and up (full criteria)
at San Francisco, California
study started
estimated completion
Haley B Naik, MD, MHSc, FAAD

Description

Summary

Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.

Keywords

Hidradenitis Suppurativa Hidradenitis

Eligibility

You can join if…

Open to people ages 13 years and up

  1. Age 13 years or older
  2. Diagnosis of HS clinically-confirmed by a physician

You CAN'T join if...

  1. Inability to give informed consent or have a parent/guardian who is able and willing to give informed consent.

Location

  • University of California, San Francisco accepting new patients
    San Francisco California 94115 United States

Lead Scientist

  • Haley B Naik, MD, MHSc, FAAD
    Hidradenitis Suppurativa (HS) is a prevalent and debilitating disease predominating in women and minorities. Despite its prevalence and morbidity, the biology of HS is poorly understood, thus limiting the development of effective therapies.

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT03967600
Study Type
Observational [Patient Registry]
Last Updated